|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 47/02 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61K 31/4422 | (2006.01) |
| (11) | Number of the document | 3522872 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17859269.7 |
| Date of filing the European patent application | 2017-10-06 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/055576 |
| Date | 2017-10-06 |
| (87) | Number | WO 2018/067959 |
| Date | 2018-04-12 |
| (30) | Number | Date | Country code |
| 201662405455 P | 2016-10-07 | US |
| (72) |
BRAUER, Scott , US
MOSHER, Gerold L. , US
|
| (73) |
Silvergate Pharmaceuticals, Inc. ,
6251 Greenwood Plaza Blvd.
Suite 101, Greenwood Village, CO 80111,
US
|
| (54) | AMLODIPINE FORMULATIONS |
| AMLODIPINE FORMULATIONS |